Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,524.40
-48.00 (-3.05%)
May 29, 2026, 3:29 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 386.75 billion as of May 29, 2026. Its market cap has increased by 11.94% in one year.
Market Cap
386.75B
Enterprise Value
397.46B
Revenue
98.21B
Ranking
n/a
PE Ratio
33.89
Stock Price
1,524.40
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 386.75B, an increase of 11,915.43%. That is a compound annual growth rate of 22.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 386.75B | 7.44% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 828.46B |
| Laurus Labs | 735.28B |
| Alkem Laboratories | 657.37B |
| Glenmark Pharmaceuticals | 641.98B |
| Gland Pharma | 370.70B |
| Ajanta Pharma | 365.78B |
| Wockhardt | 330.09B |
| Emcure Pharmaceuticals | 321.54B |